Orthofix International N.V. (OFIX) Holder Diamond Hill Capital Management Decreased Position by $3.12 Million as Stock Price Declined; Redwood Investments Upped Its Holding in Medidata Solutions (MDSO) as Market Value Rose

June 14, 2018 - By Linda Rogers

Medidata Solutions, Inc. (NASDAQ:MDSO) Logo

Ric Dillon decreased its stake in Orthofix International N.V. (OFIX) by 11.36% based on its latest 2018Q1 regulatory filing with the SEC. Diamond Hill Capital Management Inc sold 53,823 shares as the company’s stock declined 0.74% with the market. The hedge fund run by Ric Dillon held 419,909 shares of the medical and dental instruments company at the end of 2018Q1, valued at $24.68M, down from 473,732 at the end of the previous reported quarter. Diamond Hill Capital Management Inc who had been investing in Orthofix International N.V. for a number of months, seems to be less bullish one the $1.10B market cap company. The stock increased 0.74% or $0.43 during the last trading session, reaching $58.55. About 91,646 shares traded. Orthofix International N.V. (NASDAQ:OFIX) has risen 27.98% since June 14, 2017 and is uptrending. It has outperformed by 15.41% the S&P500. Some Historical OFIX News: 07/03/2018 – ORTHOFIX SECURES FDA & CE MARK APPROVALS FOR NEW PHYSIOSTIM; 22/03/2018 – ORTHOFIX INTERNATIONAL NV – ANNOUNCES U.S. FDA 510(K) CLEARANCE FOR ITS NEW INTERNAL FIXATION SYSTEM, G-BEAM FUSION BEAMING SYSTEM; 15/03/2018 – ORTHOFIX INTERNATIONAL NV – TERMS OF DEAL INCLUDE $45 MLN IN CASH CLOSING CONSIDERATION PLUS UP TO $60 MLN IN CONTINGENT MILESTONE PAYMENTS; 15/03/2018 – ORTHOFIX: PACT TO BUY SPINAL KINETICS; 22/03/2018 – Orthofix: New System Adds Treatment Options for Charcot Foot, Broadens Company’s Extremity Fixation Portfolio of Products; 15/03/2018 – Orthofix Announces Agreement to Acquire Spinal Kinetics for $45M at Closing; 15/03/2018 – ORTHOFIX INTERNATIONAL NV – SEES DEAL TO BE SLIGHTLY ACCRETIVE TO NON-GAAP DILUTED SHR, ADJUSTED EBITDA IN 12 MONTHS OF PMA APPROVAL IN U.S; 15/03/2018 – Orthofix Announces Agreement To Acquire Spinal Kinetics; 15/03/2018 – ORTHOFIX INTERNATIONAL NV – EXPECTS ACQUISITION TO ADD REVENUE IN 2018, INCREASE ORGANIC REVENUE GROWTH RATE IN 2019 AND BEYOND; 13/03/2018 – Orthofix Announces Appointment of John Sicard to Bd of Directors

Redwood Investments Llc increased its stake in Medidata Solutions Inc (MDSO) by 38.77% based on its latest 2018Q1 regulatory filing with the SEC. Redwood Investments Llc bought 81,040 shares as the company’s stock rose 10.86% while stock markets declined. The institutional investor held 290,092 shares of the technology company at the end of 2018Q1, valued at $18.22M, up from 209,052 at the end of the previous reported quarter. Redwood Investments Llc who had been investing in Medidata Solutions Inc for a number of months, seems to be bullish on the $4.78B market cap company. The stock increased 1.02% or $0.82 during the last trading session, reaching $80.82. About 276,148 shares traded. Medidata Solutions, Inc. (NASDAQ:MDSO) has risen 4.39% since June 14, 2017 and is uptrending. It has underperformed by 8.18% the S&P500. Some Historical MDSO News: 19/04/2018 – Medidata Solutions 1Q Rev $149.2M; 19/04/2018 – Medidata Solutions Sees FY18 Net $42M-Net $50M; 03/05/2018 – Medidata’s Melinda Pautsch Named a “Rising Star” by the Healthcare Businesswomen’s Association; 11/04/2018 – Medidata Closes Above 50-Day Moving Average: Technicals; 23/05/2018 – Major Cancer Center Further Advances Oncology Research by Integrating Genomic Data Into Medidata’s eClinical Platform; 15/05/2018 – Medidata Presenting at JPMorgan Conference Tomorrow; 28/03/2018 – Life Science Leaders Gather at Medidata NEXT Basel and Frankfurt to Examine New Opportunities to Improve Clinical Development and Better Patient Lives; 19/04/2018 – Medidata Solutions 1Q Net $10.3M; 27/04/2018 – Medidata Edge Strategic Monitoring Wins “Best Sponsor-Focused Technological Development” at CARE Awards 2018; 19/04/2018 – MEDIDATA SOLUTIONS INC – REMAINING 2018 ADJUSTED SUBSCRIPTION BACKLOG AS OF MARCH 31, 2018 WAS $370 MLN, AN INCREASE OF $51 MLN COMPARED WITH YEAR AGO

Among 17 analysts covering Medidata Solutions Inc. (NASDAQ:MDSO), 13 have Buy rating, 0 Sell and 4 Hold. Therefore 76% are positive. Medidata Solutions Inc. had 50 analyst reports since July 22, 2015 according to SRatingsIntel. Dougherty upgraded the stock to “Buy” rating in Monday, November 13 report. The stock of Medidata Solutions, Inc. (NASDAQ:MDSO) earned “Buy” rating by Piper Jaffray on Tuesday, June 12. On Monday, January 22 the stock rating was maintained by SunTrust with “Buy”. Deutsche Bank maintained Medidata Solutions, Inc. (NASDAQ:MDSO) rating on Thursday, May 31. Deutsche Bank has “Buy” rating and $8500 target. The rating was maintained by Needham with “Buy” on Friday, February 10. The firm has “Buy” rating by Needham given on Thursday, February 11. The rating was maintained by Deutsche Bank with “Buy” on Tuesday, September 13. KeyBanc Capital Markets initiated Medidata Solutions, Inc. (NASDAQ:MDSO) on Wednesday, September 9 with “Overweight” rating. The firm earned “Buy” rating on Sunday, October 22 by KeyBanc Capital Markets. As per Friday, February 9, the company rating was maintained by Morgan Stanley.

Redwood Investments Llc, which manages about $756.78M and $1.36 billion US Long portfolio, decreased its stake in Amazon Com Inc (NASDAQ:AMZN) by 1,777 shares to 15,223 shares, valued at $22.03M in 2018Q1, according to the filing. It also reduced its holding in Apple Inc (NASDAQ:AAPL) by 168,080 shares in the quarter, leaving it with 12,272 shares, and cut its stake in Thor Inds Inc (NYSE:THO).

Since December 19, 2017, it had 0 insider purchases, and 12 selling transactions for $6.10 million activity. 10,395 Medidata Solutions, Inc. (NASDAQ:MDSO) shares with value of $728,170 were sold by Otner Michael I.. $1.88M worth of Medidata Solutions, Inc. (NASDAQ:MDSO) shares were sold by de Vries Glen Michael. Sherif Tarek sold $1.89M worth of Medidata Solutions, Inc. (NASDAQ:MDSO) on Monday, March 12. TAYLOR ROBERT sold $285,681 worth of Medidata Solutions, Inc. (NASDAQ:MDSO) on Monday, June 4.

Investors sentiment decreased to 0.95 in 2018 Q1. Its down 0.76, from 1.71 in 2017Q4. It turned negative, as 36 investors sold MDSO shares while 74 reduced holdings. 28 funds opened positions while 76 raised stakes. 62.26 million shares or 1.96% more from 61.06 million shares in 2017Q4 were reported. Employees Retirement Association Of Colorado holds 10,300 shares or 0% of its portfolio. Hightower Advsr Limited Liability Co invested 0.01% of its portfolio in Medidata Solutions, Inc. (NASDAQ:MDSO). Riverhead Cap Management Llc holds 0.02% or 7,721 shares in its portfolio. Strs Ohio stated it has 161,997 shares. Advantus Capital Mgmt Inc holds 0.01% or 7,300 shares in its portfolio. Whetstone Advisors Ltd accumulated 66,093 shares or 2.02% of the stock. Deutsche National Bank Ag stated it has 189,690 shares. Trexquant Lp has invested 0.03% in Medidata Solutions, Inc. (NASDAQ:MDSO). Stratos Wealth Prns invested in 80 shares or 0% of the stock. Amundi Pioneer Asset Mgmt holds 0% or 21,576 shares in its portfolio. Comerica Bancorporation reported 61,772 shares. Manufacturers Life Com The owns 134,638 shares. Denver Inv Advisors Limited Co invested in 0.03% or 10,490 shares. Stephens Inv Mngmt Grp Limited holds 1.13% in Medidata Solutions, Inc. (NASDAQ:MDSO) or 828,500 shares. Comml Bank Of Montreal Can owns 25,187 shares for 0% of their portfolio.

More important recent Medidata Solutions, Inc. (NASDAQ:MDSO) news were published by: Themiddlemarket.com which released: “M&A daily wrap: Medidata, Shyft Analytics, Audax, OEP, Naked Brand” on June 12, 2018, also Seekingalpha.com published article titled: “Medidata Solutions acquires SHYFT Analytics for $195M in cash”, Streetinsider.com published: “Medidata Solutions (MDSO) PT Raised to $85 at Deutsche Bank” on May 31, 2018. More interesting news about Medidata Solutions, Inc. (NASDAQ:MDSO) was released by: Seekingalpha.com and their article: “Premarket analyst action – healthcare” with publication date: May 21, 2018.

Among 6 analysts covering Orthofix International (NASDAQ:OFIX), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Orthofix International had 11 analyst reports since August 18, 2015 according to SRatingsIntel. The stock has “Buy” rating by Jefferies on Sunday, September 10. The firm has “Buy” rating given on Wednesday, August 9 by Gabelli. As per Thursday, June 29, the company rating was maintained by Jefferies. Jefferies maintained Orthofix International N.V. (NASDAQ:OFIX) on Monday, October 30 with “Buy” rating. The firm has “Buy” rating by BTIG Research given on Tuesday, August 8. Jefferies maintained Orthofix International N.V. (NASDAQ:OFIX) on Tuesday, February 27 with “Buy” rating.

Analysts await Orthofix International N.V. (NASDAQ:OFIX) to report earnings on August, 6. They expect $0.36 EPS, down 14.29% or $0.06 from last year’s $0.42 per share. OFIX’s profit will be $6.79M for 40.66 P/E if the $0.36 EPS becomes a reality. After $0.39 actual EPS reported by Orthofix International N.V. for the previous quarter, Wall Street now forecasts -7.69% negative EPS growth.

More recent Orthofix International N.V. (NASDAQ:OFIX) news were published by: Nasdaq.com which released: “As Spinal Stocks Climb Toward Yearly Highs, There’s Still Room for Upside” on June 07, 2018. Also Seekingalpha.com published the news titled: “Premarket analyst action – healthcare” on June 01, 2018. Globenewswire.com‘s news article titled: “Factors of Influence in 2018, Key Indicators and Opportunity within Southern Missouri, Marlin Business Services …” with publication date: June 05, 2018 was also an interesting one.

Since May 3, 2018, it had 1 buying transaction, and 0 selling transactions for $519,724 activity.

Medidata Solutions, Inc. (NASDAQ:MDSO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Linda Rogers

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:








Recent Posts